MedTrace Logo

Study to Evaluate the Pharmacokinetic Characteristics and Safety of IN-C004 in Healthy Volunteers

NCT04654078 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2021-03-29

No results posted yet for this study

Summary

To evaluate the pharmacokinetic characteristics and safety of IN-C004 in healthy volunteers

Conditions

  • Healthy

Interventions

DRUG

IN-C004 with water

One time dose of IN-C004 taken with water

DRUG

IN-C004 without water

One time dose of IN-C004 taken without water

DRUG

K-CAB tab. with water

One time dose of K-CAB tab. taken with water

Sponsors & Collaborators

  • HK inno.N Corporation

    lead INDUSTRY

Principal Investigators

  • Min-Gul Kim · Chonbuk National University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-18
Primary Completion
2021-02-05
Completion
2021-02-15

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04654078 on ClinicalTrials.gov